👴Anti-Aging & Longevity

A class of molecules that boost cellular NAD+ levels to support energy metabolism, DNA repair, sirtuin activation, and anti-aging pathways — while not peptides themselves, they are commonly discussed alongside anti-aging peptides.

An investigational triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors, producing unprecedented weight loss of up to 24% in clinical trials.

A modified fragment of human growth hormone (amino acids 176-191) that stimulates lipolysis and inhibits lipogenesis without the diabetogenic or growth-promoting effects of full-length HGH.

An investigational dual glucagon and GLP-1 receptor agonist being developed for obesity and MASH (metabolic dysfunction-associated steatohepatitis) with significant liver fat reduction.

A class of ultra-short (2-4 amino acid) tissue-specific peptides developed by Prof. Vladimir Khavinson that regulate gene expression in target organs, used in Russian medicine for anti-aging and organ-specific rejuvenation.

The most popular growth hormone peptide combination, pairing a GHRH analog (CJC-1295) with a ghrelin mimetic (Ipamorelin) for synergistic GH release with minimal side effects.

An FDA-approved GLP-1 receptor agonist used for type 2 diabetes and obesity management, with cardiovascular and neuroprotective benefits.

A synergistic combination of tesamorelin (GHRH analogue) and ipamorelin (selective GHRP) that amplifies growth hormone release through dual-pathway stimulation, widely considered the gold standard GH peptide stack.

A naturally occurring copper-binding tripeptide that declines with age, known for potent wound healing, collagen stimulation, anti-aging skin effects, and hair growth promotion.

A popular clinical combination of two growth hormone secretagogues that work through complementary pathways — GHRH receptor (sermorelin) and ghrelin receptor (ipamorelin) — for synergistic GH release with minimal side effects.

The first 29 amino acids of natural GHRH, previously FDA-approved for pediatric GH deficiency. Now widely used off-label for anti-aging GH optimization as a safer alternative to direct HGH therapy.

An FDA-approved synthetic analogue of growth hormone-releasing hormone (GHRH) with a trans-3-hexenoic acid modification, indicated for HIV-associated lipodystrophy and studied for cognitive benefits and visceral fat reduction.

A tripeptide antioxidant composed of glutamate, cysteine, and glycine that serves as the body's master antioxidant, critical for detoxification, immune function, and cellular protection.

A naturally occurring dipeptide of beta-alanine and histidine found in high concentrations in muscle and brain tissue, with antioxidant, anti-glycation, and anti-aging properties.

A long-acting growth hormone-releasing hormone (GHRH) analog with a Drug Affinity Complex that extends its half-life to 6-8 days, producing sustained elevated growth hormone and IGF-1 levels.

A naturally occurring tripeptide that resets gene expression to a younger state, promoting wound healing, collagen synthesis, and anti-inflammatory effects — the copper-free precursor to GHK-Cu.

A thymic peptide bioregulator developed in Russia that restores immune function by promoting T-cell maturation and has shown anti-aging effects in clinical studies on elderly patients.

A highly selective growth hormone-releasing peptide (GHRP) that stimulates GH release with minimal impact on cortisol, prolactin, or appetite, making it the cleanest GHRP available.

An orally active, non-peptide growth hormone secretagogue that mimics ghrelin to raise GH and IGF-1 levels for up to 24 hours per dose, with notable effects on sleep, appetite, and body composition.

A modified growth hormone-releasing hormone fragment with a short half-life (~30 minutes) that stimulates pulsatile growth hormone release, closely mimicking the body's natural GH secretion pattern.

A synthetic cyclic peptide analogue of alpha-melanocyte-stimulating hormone (α-MSH) that induces skin tanning, increases libido, and reduces appetite through melanocortin receptor activation.

An FDA-approved once-weekly GLP-1 receptor agonist for type 2 diabetes with proven cardiovascular benefits and convenient single-use pen delivery.

The first GLP-1 receptor agonist approved for type 2 diabetes, originally derived from Gila monster venom, available in twice-daily and once-weekly formulations.

An oligopeptide derived from angiotensin IV that is reported to be 10 million times more potent than BDNF at enhancing cognitive function through hepatocyte growth factor (HGF) signaling.

A porcine brain-derived peptide preparation containing low-molecular-weight neuropeptides and free amino acids, used clinically in many countries for stroke recovery, traumatic brain injury, and dementia.

An 8-amino acid peptide that reduces wrinkles by inhibiting SNARE complex formation and neurotransmitter release at the neuromuscular junction, functioning as a topical 'Botox-like' anti-wrinkle treatment.

A lipopeptide used in cosmetic skincare that reduces inflammation-driven skin aging by suppressing IL-6 and other inflammatory cytokines, often paired with Palmitoyl Tripeptide-1 in anti-wrinkle formulations.

A lipopeptide that mimics the body's natural collagen-repair signal, stimulating collagen I, III, and IV synthesis and glycosaminoglycan production for anti-aging skin benefits.

A small synthetic peptide derived from ciliary neurotrophic factor (CNTF) that promotes neurogenesis and enhances cognitive function by inhibiting leukemia inhibitory factor (LIF) signaling.

A short tripeptide bioregulator that targets the pineal gland, supporting melatonin production, sleep quality, and neuroprotection.

A zinc-dependent nonapeptide hormone produced by thymic epithelial cells that plays an essential role in T-cell differentiation and immune regulation, declining significantly with age.

Bioactive peptide fragments derived from hydrolyzed collagen protein that support skin elasticity, joint health, bone density, hair/nail growth, and gut lining integrity through stimulation of endogenous collagen synthesis.

A class of biological agents that block myostatin (GDF-8), the body's primary muscle growth inhibitor, enabling significant increases in muscle mass — the 'holy grail' of muscle-building therapeutics.

A small molecule NNMT (nicotinamide N-methyltransferase) inhibitor that promotes fat loss by increasing NAD+ levels and cellular energy metabolism, available as an oral compound.

A lipopeptide used in cosmetic skincare that stimulates collagen and extracellular matrix production, often marketed as a non-invasive alternative to retinol for anti-wrinkle treatment.

A modified version of insulin-like growth factor 1 with an extended half-life, potently promoting muscle growth, hyperplasia, and recovery through direct anabolic signaling.

The full-length 43-amino acid peptide from which TB-500 is derived, with comprehensive tissue repair, anti-inflammatory, and regenerative properties across virtually all tissue types.

An 11-amino acid synthetic peptide derived from erythropoietin (EPO) that promotes tissue repair and neuroprotection without stimulating red blood cell production.

A synthetic hexapeptide that inhibits neurotransmitter release at the neuromuscular junction, reducing facial muscle contraction and wrinkle formation — often called 'Botox in a bottle'.

A 32-amino acid peptide hormone produced by thyroid C-cells that inhibits osteoclast activity and lowers blood calcium, used therapeutically for osteoporosis and hypercalcemia.

A copper-binding tripeptide that stimulates collagen production, promotes hair follicle growth, and supports wound healing, offering similar but distinct benefits to the more well-known GHK-Cu.

A family of cardiac hormones that regulate blood pressure, fluid balance, and cardiac function — used clinically for heart failure diagnosis and treatment, and increasingly studied for cardioprotective benefits.

A heptapeptide fragment of adrenocorticotropic hormone that enhances memory, attention, and learning without the adrenal-stimulating effects of full-length ACTH, serving as the basis for nootropic peptides like Semax.

An anti-inflammatory and anti-allergic compound that inhibits IKKε and TBK1 kinases, showing promise for obesity, type 2 diabetes, and metabolic syndrome through unique energy expenditure mechanisms.

An experimental oral growth hormone secretagogue peptide designed to stimulate GH release through the ghrelin receptor, offering a potential alternative to injectable GH-releasing peptides.

A glycoprotein that inhibits myostatin and activin, removing the body's natural brake on muscle growth and enabling significant increases in lean muscle mass.

A synthetic analog of alpha-melanocyte stimulating hormone (α-MSH) that stimulates melanin production for photoprotection, FDA-approved (as Scenesse) for erythropoietic protoporphyria (EPP).

A PEGylated growth hormone receptor antagonist that blocks GH action at the receptor level, used to treat acromegaly by normalizing IGF-1 levels without reducing GH secretion.

A semi-synthetic polysaccharide (heparin-like compound) used clinically for interstitial cystitis and osteoarthritis, with disease-modifying effects on cartilage, joints, and the glycosaminoglycan layer.

An experimental nootropic peptide investigated for cognitive enhancement, neuroprotection, and memory improvement, derived from research into growth hormone fragments and neural signaling.